Search

everythinglearnresearchcommunity

for

Search:↓

Many women with hard-to-treat acne also have PCOS.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Hormonal therapies are safe and effective for treating adult women's acne.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

GLPLS and LPP are variants of lichen planus.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.